Showing results (221-230 of 1,560) with videos related to
Sort By:
Pageof 156
Asia-Pacific Journal of Clinical Oncology|May 29, 2024
Breast conservation versus mastectomy for metaplastic breast cancer: A systematic review and meta-analysisChristopher G Harris, Farhad Azimi, Belinda Chan, et al.Asia-Pacific Journal of Clinical Oncology|July 6, 2024
Non-alcoholic fatty liver disease increases the risk of biochemical recurrence in high-grade metastatic prostate cancer patientsHongyi Zhang, Wenbo Yang, Bin Zhang, et al.Asia-Pacific Journal of Clinical Oncology|May 21, 2024
Neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for borderline-resectable pancreatic cancerYusuke Okamura, Ryuta Nishitai, Naoya Sasaki, et al.Asia-Pacific Journal of Clinical Oncology|July 18, 2023
Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC followed by radical cystectomy in Korean patients with muscle-invasive or locally advanced urothelial carcinoma of bladderKwonoh Park, Hyun Jung Lee, Tae Un Kim, et al.Asia-Pacific Journal of Clinical Oncology|July 12, 2023
Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population-based studyGuo Yuan How, Chik Hong Kuick, Min Hwee Yong, et al.Asia-Pacific Journal of Clinical Oncology|January 30, 2019
Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controlsMohammad Hashemi, Abdolkarim Moazeni-Roodi, Mohsen TaheriAsia-Pacific Journal of Clinical Oncology|December 4, 2018
The effects of switching EGFR-TKI treatments for non-small cell lung cancer because of adverse eventsYoshihiko Sakata, Kodai Kawamura, Naoki Shingu, et al.Asia-Pacific Journal of Clinical Oncology|September 23, 2020
A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinomaYao-Chung Liu, Chien-Wei Su, Po-Shen Ko, et al.Asia-Pacific Journal of Clinical Oncology|September 24, 2020
Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigationAlexander Yuile, Claudia Fanuli, Sheryl van Nunen, et al.Asia-Pacific Journal of Clinical Oncology|September 26, 2020
Radiotherapy service need in the Pacific Island countriesJesmin Shafiq, Gabriel Sam Gabriel, Michael B BartonPageof 156